Immunogenicity and Safety of Childhood Combination Vaccines: A Systematic Review and Meta-Analysis

Immunogenicity and Safety of Childhood Combination Vaccines: A Systematic Review and Meta-Analysis

Background: Vaccination is considered the most effective and economical measure for controlling infectious diseases. Although combination vaccines are widely used worldwide, whether any of the combination vaccines is superior to each separate vaccine has yet to be established. This systematic review...

Full description

Bibliographic Details
Main Authors:	Bei Liu, Bing Cao, Chao Wang, Bingfeng Han, Tao Sun, Yudong Miao, Qingbin Lu, Fuqiang Cui
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Vaccines
Subjects:	combined vaccine meta-analysis infants immunogenicity safety
Online Access:	https://www.mdpi.com/2076-393X/10/3/472

Similar Items

Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis
by: Jianming Guo, et al.
Published: (2023-02-01)

Comparison of the Immunogenicity and Safety of Three Enhanced Inactivated Poliovirus Vaccines from Different Manufacturers in Healthy Korean Infants: A Prospective Multicenter Study
by: Byung Ok Kwak, et al.
Published: (2020-04-01)

Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
by: Nadim Sharif, et al.
Published: (2021-10-01)

The immunogenicity and safety of the new, Indonesian DTwP-HB-Hib vaccine compared to the DTwP/HB vaccine given with the Hib vaccine
by: Novilia Sjafri Bachtiar, et al.
Published: (2017-06-01)

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
by: Osamu Matsuoka, et al.
Published: (2018-02-01)

Immunogenicity and safety of a 12-valent pneumococcal conjugate vaccine in infants aged 6–10 weeks: a randomized double-blind active-controlled trial
by: Jonghoon Shin, et al.
Published: (2020-07-01)

Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial
by: Zhi-Wei Wu, et al.
Published: (2021-07-01)

A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants
by: Yasunori Ishihara, et al.
Published: (2024-04-01)

Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis
by: Yu Liang, et al.
Published: (2021-10-01)

Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine
by: Ramy Mohamed Ghazy, et al.
Published: (2023-11-01)

Safety of Global SARS-CoV-2 Vaccines, a Meta-Analysis
by: Linyi Chen, et al.
Published: (2022-04-01)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
by: Eva Hong, et al.
Published: (2017-03-01)

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
by: Mingzhu Li, et al.
Published: (2023-03-01)

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
by: Andrea Guerra, et al.
Published: (2024-12-01)

Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review
by: Neelam Asghar, et al.
Published: (2022-10-01)

Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
by: Hui Xuan Lim, et al.
Published: (2021-11-01)

The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysisResearch in context
by: Eve Nakabembe, et al.
Published: (2024-03-01)

Immunogenicity and safety of adjuvant-associated COVID-19 vaccines: A systematic review and meta-analysis of randomized controlled trials
by: Meng-Qun Cheng, et al.
Published: (2023-12-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011-02-01)

Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study
by: Paul Gillard, et al.
Published: (2019-04-01)

Evaluation of immunogenicity and safety of VARIVAX™ New Seed Process (NSP) in children
by: Shelly D. Senders, et al.
Published: (2018-02-01)

Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models
by: Huayue Ye, et al.
Published: (2020-11-01)

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial
by: Zhi-Wei Wu, et al.
Published: (2023-08-01)

Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines
by: Priya Pereira, et al.
Published: (2020-11-01)

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
by: Shibadas Biswal, et al.
Published: (2021-06-01)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
by: Marissa B. Wilck, et al.
Published: (2021-01-01)

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial
by: Wenjuan Wang, et al.
Published: (2022-01-01)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
by: Helen L. Stacey, et al.
Published: (2019-03-01)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
by: James T. Peterson, et al.
Published: (2019-03-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
by: Xiaoyuan Huang, et al.
Published: (2023-01-01)

THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS
by: I. V. Feldblum, et al.
Published: (2014-06-01)

Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination：a meta-analysis
by: Mingjuan Yin, et al.
Published: (2018-04-01)

Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older
by: David P. Greenberg, et al.
Published: (2017-09-01)

Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials
by: Juntao Yin, et al.
Published: (2024-12-01)

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants
by: Shuyu Gao, et al.
Published: (2022-11-01)

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
by: Nan-Chang Chiu, et al.
Published: (2018-05-01)

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines
by: Maria Rosario Z. Capeding, et al.
Published: (2017-10-01)

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017-04-01)

Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
by: Ainur Nurpeisova, et al.
Published: (2022-11-01)

Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of age
by: Tia Aoun, et al.
Published: (2023-12-01)